Showing 9,341 - 9,360 results of 18,700 for search 'significantly ((((step decrease) OR (((a decrease) OR (mean decrease))))) OR (observed decrease))', query time: 0.69s Refine Results
  1. 9341

    Image 1_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.tif by Yongyi Zhang (1800337)

    Published 2025
    “…Subgroup analyses revealed that the efficacy of levetiracetam was superior to that of sodium valproate (OR 0.53, 95% CI 0.39–0.72, p < 0.0001) and phenytoin sodium (OR 0.35, 95% CI 0.19–0.62, p = 0.0004). No statistically significant difference in the efficacy of early seizure prophylaxis (OR 0.55, 95% CI 0.15–2.04, p = 0.37) was observed. …”
  2. 9342

    Image 2_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.tif by Yongyi Zhang (1800337)

    Published 2025
    “…Subgroup analyses revealed that the efficacy of levetiracetam was superior to that of sodium valproate (OR 0.53, 95% CI 0.39–0.72, p < 0.0001) and phenytoin sodium (OR 0.35, 95% CI 0.19–0.62, p = 0.0004). No statistically significant difference in the efficacy of early seizure prophylaxis (OR 0.55, 95% CI 0.15–2.04, p = 0.37) was observed. …”
  3. 9343

    Image 4_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.tif by Yongyi Zhang (1800337)

    Published 2025
    “…Subgroup analyses revealed that the efficacy of levetiracetam was superior to that of sodium valproate (OR 0.53, 95% CI 0.39–0.72, p < 0.0001) and phenytoin sodium (OR 0.35, 95% CI 0.19–0.62, p = 0.0004). No statistically significant difference in the efficacy of early seizure prophylaxis (OR 0.55, 95% CI 0.15–2.04, p = 0.37) was observed. …”
  4. 9344

    Supplementary file 3_Efficacy of Xiaoyao-san preparations in treating Hashimoto’s thyroiditis: a meta-analysis and systematic review.docx by Chengna Wang (21535973)

    Published 2025
    “…</p>Methods<p>Eight databases were searched for randomized controlled trials (RCTs) comparing XYS preparations to a low-iodine diet (LID), selenium yeast (SY), levothyroxine (LT4), or Ophiocordyceps sinensis (OS) for HT treatment. …”
  5. 9345

    Supplementary file 2_Efficacy of Xiaoyao-san preparations in treating Hashimoto’s thyroiditis: a meta-analysis and systematic review.zip by Chengna Wang (21535973)

    Published 2025
    “…</p>Methods<p>Eight databases were searched for randomized controlled trials (RCTs) comparing XYS preparations to a low-iodine diet (LID), selenium yeast (SY), levothyroxine (LT4), or Ophiocordyceps sinensis (OS) for HT treatment. …”
  6. 9346

    Supplementary file 1_Efficacy of Xiaoyao-san preparations in treating Hashimoto’s thyroiditis: a meta-analysis and systematic review.zip by Chengna Wang (21535973)

    Published 2025
    “…</p>Methods<p>Eight databases were searched for randomized controlled trials (RCTs) comparing XYS preparations to a low-iodine diet (LID), selenium yeast (SY), levothyroxine (LT4), or Ophiocordyceps sinensis (OS) for HT treatment. …”
  7. 9347

    GRADE judgements. by Da Huang (1306407)

    Published 2025
    “…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”
  8. 9348

    Basic characteristics of the included studies. by Da Huang (1306407)

    Published 2025
    “…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”
  9. 9349

    The data of meta-analysis. by Da Huang (1306407)

    Published 2025
    “…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”
  10. 9350

    Risk of bias. by Da Huang (1306407)

    Published 2025
    “…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”
  11. 9351

    Overall risk of bias assessment. by Da Huang (1306407)

    Published 2025
    “…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”
  12. 9352

    Funnel plot of VO<sub>2Peak</sub> inclusion studies. by Da Huang (1306407)

    Published 2025
    “…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”
  13. 9353

    Analysis of subgroups. by Da Huang (1306407)

    Published 2025
    “…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”
  14. 9354
  15. 9355

    Data Sheet 1_Electroacupuncture treatment can improve cognitive impairment in spontaneously hypertensive rats: a preliminary DTI study.docx by Ji-peng Liu (14764009)

    Published 2025
    “…Background<p>Hypertension is a significant risk factor for cognitive impairment. …”
  16. 9356

    Data Sheet 1_Fungal planktonic community related to salinity and temperature in an oligotrophic sea.docx by Ashwag A. Asseri (20633438)

    Published 2025
    “…Overall, our study described a differential distribution of the most dominant fungal classes, with potential significance in their control of planktonic populations and consequent influence in the carbon cycle in the Red Sea ecosystem. …”
  17. 9357

    Proposed model of how morphological plasticity contributes to echinocandin tolerance acquisition in <i>C. tropicalis</i> clinical isolates. by Yongqin Wu (272012)

    Published 2025
    “…In contrast, non-tolerant strains swell or even rupture, accompanied by a significant thickening of the cell wall, and a marked increase in both chitin and glucan content. …”
  18. 9358
  19. 9359

    DataSheet1_Glioma-associated oncogene homolog 1 in breast invasive carcinoma: a comprehensive bioinformatic analysis and experimental validation.docx by Teng Qi (278739)

    Published 2024
    “…</p>Results<p>The findings reveal dysregulated expression of GLI1 in numerous cancers, with a significant decrease observed in BRCA. High GLI1 expression indicated better survival outcomes and was correlated with the age and stage of BRCA patients. …”
  20. 9360

    Supplementary tables: Assessing healthcare resource utilization burden and unmet treatment needs in patients with Parkinson’s disease: results from a real-world study by Malgorzata Ciepielewska (22143499)

    Published 2025
    “…The intermediate versus early group had a significantly greater proportion of patients with unmet treatment needs (p < 0.001), e.g., slowing disease progression, providing neuroprotection. …”